Centrafarm Services B.V. Pharmathen International S.A. Pharmathen S.A. STADA Arzneimittel AG
PolandAll drugs from this manufacturer
-
The medicine is used in adults and adolescents (from 12 years of age) to prevent nausea and vomiting induced by chemotherapy (anticancer treatment).
Dosage form: capsules, hard
Active substance Dosage aprepitant 125 mg or 80 mg ATC: A04AD12
-
The medicine is used in adult patients to control the immune system response after organ transplantation (e.g., liver or kidney) to prevent rejection. It may also be used in the event of transplant rejection if other treatments have not been effective.
Dosage form: capsules, extended release, hard
Active substance Dosage tacrolimus 0.5 mg ATC: L04AD02
-
The medicine is used in adult patients to control the immune system response after organ transplantation (e.g., liver or kidney) to prevent rejection. It may also be used in cases of rejection of a transplanted liver, kidney, heart, or other organs if previous treatment has not been effective.
Dosage form: capsules, extended release, hard
Active substance Dosage tacrolimus 1.022 mg ATC: L04AD02
-
The medicine is used in adult patients to control the immune system response after organ transplantation (e.g., liver or kidney) to prevent rejection. It may also be used in the event of rejection of a transplanted organ if other treatments have not been effective.
Dosage form: capsules, extended release, hard
Active substance Dosage tacrolimus 3.0659 mg ATC: L04AD02
-
The medicinal product is used in adult patients to control the immune response after organ transplantation (e.g., liver or kidney) to prevent rejection. It may also be used in cases of rejection of a transplanted liver, kidney, heart, or other organs if other treatments have not been effective.
Dosage form: capsules, extended release, hard
Active substance Dosage tacrolimus 5.1097 mg ATC: L04AD02